Immunohistochemical study of α-smooth muscle actin expression in oral leukoplakia and oral squamous cell carcinoma.

Myofibroblasts oral leukoplakia oral squamous cell carcinoma α-smooth muscle actin

Journal

Journal of oral and maxillofacial pathology : JOMFP
ISSN: 0973-029X
Titre abrégé: J Oral Maxillofac Pathol
Pays: India
ID NLM: 101227995

Informations de publication

Date de publication:
Historique:
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 22 5 2019
Statut: ppublish

Résumé

It is important to evaluate the role of stromal myofibroblasts (MFs) in carcinogenesis and also as a predictive marker for lymph node (LN) metastasis at the invasive front of oral squamous cell carcinoma (OSCC). To demonstrate the expression of α-smooth muscle actin (α-SMA) by MFs in the tissues of oral leukoplakia (OL) with dysplasia and OSCC. To record and compare the distribution of MFs in OSCC with LN metastasis and without LN metastasis. Fifty paraffin-embedded tissue blocks with 10 cases of normal oral mucosa, 10 cases of OL with dysplasia and 30 diagnosed cases of OSCCs were studied. The samples were subjected to heat-induced antigen retrieval method followed by staining using primary mouse monoclonal antibodies against α-SMA and visualized using super sensitive polymer-HRP detection system. Descriptive statistical analysis and ANOVA test were used for statistical analysis. There was no α-SMA expression in normal oral mucosa or in OL with dysplasia. All tissues of OSCC were positive for α-SMA expression. The difference in the expression between OL with dysplasia and OSCC was statistically significant ( α-SMA expression by MFs in OSCCs indicates its role in tumor growth and invasion. The mean α-SMA count was found to correlate with tumor invasiveness and locoregional LN metastasis.

Identifiants

pubmed: 31110418
doi: 10.4103/jomfp.JOMFP_94_18
pii: JOMFP-23-59
pmc: PMC6503784
doi:

Types de publication

Journal Article

Langues

eng

Pagination

59-64

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Crit Rev Oral Biol Med. 2001;12(6):499-510
pubmed: 11806519
J Pathol. 2003 Jul;200(4):429-47
pubmed: 12845611
Br J Cancer. 2004 Feb 23;90(4):822-32
pubmed: 14970860
Oral Oncol. 2005 Nov;41(10):1028-33
pubmed: 16139563
Oral Oncol. 2008 May;44(5):509-17
pubmed: 17826300
Histopathology. 2007 Dec;51(6):849-53
pubmed: 18042073
Curr Opin Genet Dev. 2008 Feb;18(1):27-34
pubmed: 18282701
Arch Iran Med. 2008 May;11(3):341-3
pubmed: 18426330
Head Neck. 2009 Oct;31(10):1346-53
pubmed: 19373786
Cancer Microenviron. 2009 Dec;2(1):49-57
pubmed: 19424824
J Oral Pathol Med. 2009 Sep;38(8):639-43
pubmed: 19473444
Asian Pac J Cancer Prev. 2010;11(2):359-64
pubmed: 20843116
J Oral Pathol Med. 2011 Mar;40(3):201-7
pubmed: 21342271
Med Oral Patol Oral Cir Bucal. 2012 Sep 01;17(5):e733-8
pubmed: 22322518
Crit Rev Oral Biol Med. 1995;6(2):147-60
pubmed: 7548621

Auteurs

A Smitha (A)

Department of Oral Pathology and Microbiology, Bangalore Institute of Dental Sciences and Hospital, Bengaluru, Karnataka, India.

Kavita Rao (K)

Department of Oral and Maxillofacial Pathology, V. S. Dental College and Hospital, Bengaluru, Karnataka, India.

H S Umadevi (HS)

Department of Oral and Maxillofacial Pathology, V. S. Dental College and Hospital, Bengaluru, Karnataka, India.

T Smitha (T)

Department of Oral and Maxillofacial Pathology, V. S. Dental College and Hospital, Bengaluru, Karnataka, India.

H S Sheethal (HS)

Department of Oral and Maxillofacial Pathology, V. S. Dental College and Hospital, Bengaluru, Karnataka, India.

M A Vidya (MA)

Department of Oral Pathology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India.

Classifications MeSH